The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published Date:

Abstract

We provide an overview of the latest evidence on computer-aided detection (CAD) software for automated interpretation of chest radiographs (CXRs) for TB detection. CAD is a useful tool that can assist in rapid and consistent CXR interpretation for TB. CAD can achieve high sensitivity TB detection among people seeking care with symptoms of TB and in population-based screening, has accuracy on-par with human readers. However, implementation challenges remain. Due to diagnostic heterogeneity between settings and sub-populations, users need to select threshold scores rather than use pre-specified ones, but some sites may lack the resources and data to do so. Efficient standardisation is further complicated by frequent updates and new CAD versions, which also challenges implementation and comparison. CAD has not been validated for TB diagnosis in children and its accuracy for identifying non-TB abnormalities remains to be evaluated. A number of economic and political issues also remain to be addressed through regulation for CAD to avoid furthering health inequities. Although CAD-based CXR analysis has proven remarkably accurate for TB detection in adults, the above issues need to be addressed to ensure that the technology meets the needs of high-burden settings and vulnerable sub-populations.

Authors

  • C Geric
    Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Montreal, QC, Canada, McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • Z Z Qin
    Stop TB Partnership, Geneva, Switzerland, Division of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany.
  • C M Denkinger
    Division of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital, Heidelberg, Germany, German Centre for Infection Research (DZIF), partner site of Heidelberg University Hospital, Heidelberg, Germany.
  • S V Kik
    FIND, the Global Alliance for Diagnostics, Geneva, Switzerland.
  • B Marais
    Sydney Medical School and Sydney Infectious Diseases Institute, The University of Sydney, Westmead, NSW, Australia.
  • A Anjos
    Idiap Research Institute, Martigny, Switzerland.
  • P-M David
    Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada.
  • F Ahmad Khan
    Division of Experimental Medicine, Department of Medicine, McGill University, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Montreal, QC, Canada, McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
  • A Trajman
    McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, Departamento de Clínica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.